닫기
검색

ScienceON 논문 검색

  • home
  • ScienceON 논문 검색
search

검색어 : 통합검색[Maynard Lucian]

7건 중 7건 출력

, 1/1 페이지

  • 1
    Reviews : Cooking for Diabetics, by Kitty Maynard, RN; Lucian Maynard, RN; and Theodore Duncan, MD. (1989). Rutledge Hill Press, 513 Third Avenue South, Nashville, TN 37210. 217 pages. Price: $17.95
    McAfee, Frances; ; (The Diabetes educator, v.15, 1989, pp.425-427)
  • 2
    Abstract B01: BLU-667: A highly selective RET inhibitor to target RET-driven NSCLC
    Rahal, Rami; Maynard, Michelle; Hu, Wei; Brubaker, Jason; Cao, Qiangfang; Kim, Joseph L.; Sheets, Michael P.; Wilson, Douglas P.; Wilson, Kevin J.; DiPietro, Lucian; LaBranche, Timothy; Wolf, Beni; Guzi, Timothy; Lengauer, Christoph; Evans, Erica K.; ; (Clinical Cancer research : an official journal of the American Association for Cancer Research, v.24, 2018, pp.B01-B01)
  • 3
    Abstract 2641: The development of potent, selective RET inhibitors that target both wild-type RET and prospectively identified resistance mutations to multi-kinase inhibitors
    Rahal, Rami; Evans, Erica K.; Hu, Wei; Maynard, Michelle; Fleming, Paul; DiPietro, Lucian; Kim, Joseph L.; Sheets, Michael P.; Wilson, Doug P.; Wilson, Kevin J.; Stransky, Nicolas; Brubaker, Jason D.; Guzi, Timothy; Kohl, Nancy E.; Lengauer, Christoph; Blueprint Medicines, Cambridge, MA.; Blueprint Medicines, Cambridge, MA.; Blueprint Medicines, Cambridge, MA.; Blueprint Medicines, Cambridge, MA.; Blueprint Medicines, Cambridge, MA.; Blueprint Medicines, Cambridge, MA.; Blueprint Medicines, Cambridge, MA.; Blueprint Medicines, Cambridge, MA.; Blueprint Medicines, Cambridge, MA.; Blueprint Medicines, Cambridge, MA.; Blueprint Medicines, Cambridge, MA.; Blueprint Medicines, Cambridge, MA.; Blueprint Medicines, Cambridge, MA.; Blueprint Medicines, Cambridge, MA.; Blueprint Medicines, Cambridge, MA.; (Cancer research : the official organ of the American Association for Cancer Research, Inc, v.76, 2016, pp.2641-2641)
  • 4
    Abstract B151: BLU-667 is a potent and highly selective RET inhibitor being developed for <i>RET</i>-driven cancers
    Rahal, Rami; Maynard, Michelle; Hu, Wei; Brubaker, Jason; Cao, Qiongfang; Kim, Joseph L.; Sheets, Michael P.; Wilson, Douglas P.; Wilson, Kevin J.; DiPietro, Lucian; Fleming, Paul; LaBranche, Timothy P.; Wolf, Beni; Guzi, Timothy; Lengauer, Christoph; Evans, Erica K.; ; (Molecular cancer therapeutics, v.17, 2018, pp.B151-B151)
  • 5
    Precision Targeted Therapy with BLU-667 for <i>RET</i>-Driven Cancers
    Subbiah, Vivek; Gainor, Justin F.; Rahal, Rami; Brubaker, Jason D.; Kim, Joseph L.; Maynard, Michelle; Hu, Wei; Cao, Qiongfang; Sheets, Michael P.; Wilson, Douglas; Wilson, Kevin J.; DiPietro, Lucian; Fleming, Paul; Palmer, Michael; Hu, Mimi I.; Wirth, Lori; Brose, Marcia S.; Ou, Sai-Hong Ignatius; Taylor, Matthew; Garralda, Elena; Miller, Stephen; Wolf, Beni; Lengauer, Christoph; Guzi, Timothy; Evans, Erica K.; Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.; Blueprint Medicines Corporation, Cambridge, Massachusetts.; Blueprint Medicines Corporation, Cambridge, Massachusetts.; Blueprint Medicines Corporation, Cambridge, Massachusetts.; Blueprint Medicines Corporation, Cambridge, Massachusetts.; Blueprint Medicines Corporation, Cambridge, Massachusetts.; Blueprint Medicines Corporation, Cambridge, Massachusetts.; Blueprint Medicines Corporation, Cambridge, Massachusetts.; Blueprint Medicines Corporation, Cambridge, Massachusetts.; Blueprint Medicines Corporation, Cambridge, Massachusetts.; Blueprint Medicines Corporation, Cambridge, Massachusetts.; Blueprint Medicines Corporation, Cambridge, Massachusetts.; Blueprint Medicines Corporation, Cambridge, Massachusetts.; Department of Endocrine Neoplasia and; (Cancer discovery, v.8, 2018, pp.836-849)
  • 6
    Chronic Hepatitis B Treatment Initiation and Modification Patterns in Five European Countries: A 2-Year Longitudinal, Non-Interventional Study
    Marcellin, Patrick; Arama, Victoria; Leblebicioglu, Hakan; Zarski, Jean Pierre; Zeuzem, Stefan; Mauss, Stefan; Sieklucki, Jerzy; Acalovschi, Monica; Usluer, Gaye; Klauck, Isabelle; Morais, Edith; Bjork, Stefan; Lescrauwaet, Benedicte; Kamar, Driss; Simon, Krzysztof; Botta-Fridlund, Danielle; Pol, Stanislas; Maynard, Marianne; Habersetzer, Franç ois; Causse, Xavier; Alric, Laurent; Simo Noumbissie, Pauline; Gerken, Guido; Goeser, Tobias; Niederau, Claus; Wiese, Manfred; Busch, Heiner; Schneider, Lothar; Schubert, Jens; Brenner, Meike; Scheffrahn, Inka; Vermehren, Johannes; Bludzin, Wieslawa; Dziambor, Andrzej; Goryszewski, Dariusz; Postawa-Klosinska, Barbara; Pleś niak, Robert; Tanasescu, Coman; Raducan, Lucian; Sporea, Ioan; Jinga, Mariana; Voiculescu, Mihai; Chira, Olimpia; Stefan Arama, Sorin; Andreea Radulescu, Mihaela; Nicolau, Adriana; Nitescu, Doina; Nanu, Andrei; Dan, Isabel; Nicolita, Diana; Ionescu, Camelia; Ecobici; Service Hepato-Gastroenterology, Hopital Beaujon, Paris, France; Carol Davila University of Medicine and Pharmacy, Bucharest, Romania; Department of Infectious Diseases and Clinical Microbiology, Medical School, Ondokuz Mayis University, Samsun, Turkey; Clinique Universitaire d'Hé pato-Gastroenté rologie, CHU de Grenoble, Grenoble, France; Department of Medicine, JW Goethe University Hospital, Frankfurt, Germany; Center for HIV and Hepatogastroenterology, Duesseldorf, Germany; Department of Infectious Diseases, Medical Center, Łań cut, Poland; University of Medicine and Pharmacy, Cluj-Napoca, Romania; Department of Infectious Diseases and Clinical Microbiology, Medical School, Osmangazi University, Eskisehir, Turkey; Bristol-Myers Squibb, Paris, France; Bristol-Myers Squibb, Paris, France; Service Hepato-Gastroenterology, Hopital Beaujon, Paris, France; Service Hepato-Gastroenterology, Hopital Beaujon, Paris, France; Service Hepato-Gastroenterology, Hopi; (Antiviral therapy, v.19, 2014, pp.235-243)
  • 7
    Chronic Hepatitis B Monitoring and Treatment Patterns in Five European Countries with Different Access and Reimbursement Policies
    Arama, Victoria; Leblebicioglu, Hakan; Simon, Krzysztof; Zarski, Jean Pierre; Niederau, Claus; Habersetzer, Franç ois; Vermehren, Johannes; Bludzin, Wieslawa; Jinga, Mariana; Ulusoy, Sercan; Klauck, Isabelle; Morais, Edith; Bjork, Stefan; Lescrauwaet, Benedicte; Kamar, Driss; Zeuzem, Stefan; Marcellin, Patrick; Botta-Fridlund, Danielle; Pol, Stanislas; Maynard, Marianne; Habersetzer, Franç ois; Causse, Xavier; Alric, Laurent; Simo Noumbissie, Pauline; Mauss, Stefan; Gerken, Guido; Goeser, Tobias; Wiese, Manfred; Busch, Heiner; Schneider, Lothar; Schubert, Jens; Brenner, Meike; Scheffrahn, Inka; Dziambor, Andrzej; Goryszewski, Dariusz; Postawa-Klosinska, Barbara; Sieklucki, Jerzy; Pleś niak, Robert; Acalovschi, Monica; Tanasescu, Coman; Raducan, Lucian; Sporea, Ioan; Voiculescu, Mihai; Chira, Olimpia; Stefan Arama, Sorin; Andreea Radulescu, Mihaela; Nicolau, Adriana; Nitescu, Doina; Munteanu, Daniela Ioana; Nanu, Andrei; Carol Davila University of Medicine and Pharmacy, Bucharest, Romania; Department of Infectious Diseases and Clinical Microbiology, Medical School, Ondokuz Mayis University, Samsun, Turkey; Wroclaw University of Medicine, Wroclaw, Poland; Clinique Universitaire d'Hé pato-Gastroenté rologie, CHU de Grenoble, Grenoble, France; Katholische Kliniken Oberhausen, St Josef Hospital, Klinik fü r Innere Medizin, Oberhausen, Germany; Pô le Hé pato-digestif, Unité Inserm U.1110, Université de Strasbourg, Laboratoire d'Excellence HepSys, Strasbourg, France; Medizinische Klinik 1, Klinikum der JW Goethe-Universitä t, Frankfurt am Main, Germany; Szpital Wojew. w Opolu, Opole, Poland; Dr Carol Davila Central University Emergency Military Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania; Carol Davila University of Medicine and Pharmacy, Bucharest, Romania; Bristol-Myers Squibb, Paris, France; Bristol-Myers Squibb, Par; (Antiviral therapy, v.19, 2014, pp.245-257)
1

처음 오셨나요?